Literature DB >> 22252815

Klebsiella pneumoniae ST258 producing KPC-3 identified in italy carries novel plasmids and OmpK36/OmpK35 porin variants.

Aurora García-Fernández1, Laura Villa, Claudio Carta, Carolina Venditti, Alessandra Giordano, Mario Venditti, Carlo Mancini, Alessandra Carattoli.   

Abstract

A carbapenemase-resistant Klebsiella pneumoniae strain, clone ST258 producing KPC-3, was fully characterized. The entire plasmid content was investigated, thereby identifying plasmids of the IncFII(k) (two of them similar to pKPQIL and pKPN3, respectively), IncX, and ColE types, carrying a formidable set of resistance genes against toxic compounds, metals, and antimicrobial drugs and a novel iron(III) uptake system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252815      PMCID: PMC3318348          DOI: 10.1128/AAC.05308-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase.

Authors:  G Arlet; M Rouveau; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1997-07-01       Impact factor: 2.742

3.  Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum beta-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae.

Authors:  C Mabilat; S Goussard; W Sougakoff; R C Spencer; P Courvalin
Journal:  Plasmid       Date:  1990-01       Impact factor: 3.466

4.  Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.

Authors:  Laure Diancourt; Virginie Passet; Jan Verhoef; Patrick A D Grimont; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals.

Authors:  M L Mezzatesta; F Gona; C Caio; V Petrolito; D Sciortino; A Sciacca; C Santangelo; S Stefani
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

6.  High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.

Authors:  Frank M Kaczmarek; Fadia Dib-Hajj; Wenchi Shang; Thomas D Gootz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.

Authors:  Neil Woodford; Jiancheng Zhang; Marina Warner; Mary E Kaufmann; Jorge Matos; Alan Macdonald; Daniel Brudney; David Sompolinsky; Shiri Navon-Venezia; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2008-09-23       Impact factor: 5.790

8.  Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.

Authors:  J Kamile Rasheed; James W Biddle; Karen F Anderson; Laraine Washer; Carol Chenoweth; John Perrin; Duane W Newton; Jean B Patel
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

9.  Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.

Authors:  Ørjan Samuelsen; Umaer Naseer; Ståle Tofteland; Dag Harald Skutlaberg; Annette Onken; Reidar Hjetland; Arnfinn Sundsfjord; Christian G Giske
Journal:  J Antimicrob Chemother       Date:  2009-02-13       Impact factor: 5.790

10.  Molecular detection of GES-2 extended spectrum Beta-lactamase producing Pseudomonas aeruginosa in Pretoria, South Africa.

Authors:  Gerhard F Weldhagen; Andrea Prinsloo
Journal:  Int J Antimicrob Agents       Date:  2004-07       Impact factor: 5.283

View more
  86 in total

1.  Characterization of Tn3000, a Transposon Responsible for blaNDM-1 Dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India.

Authors:  Juliana Coutinho Campos; Maria José Félix da Silva; Paulo Roberto Nascimento dos Santos; Elaine Menezes Barros; Mayne de Oliveira Pereira; Bruna Mara Silva Seco; Cibele Massotti Magagnin; Leonardo Kalab Leiroz; Théo Gremen Mimary de Oliveira; Célio de Faria-Júnior; Louise Teixeira Cerdeira; Afonso Luís Barth; Suely Carlos Ferreira Sampaio; Alexandre Prehn Zavascki; Laurent Poirel; Jorge Luiz Mello Sampaio
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Molecular Characterization of an Atypical IncX3 Plasmid pKPC-NY79 Carrying bla KPC-2 in a Klebsiella pneumoniae.

Authors:  Pak-Leung Ho; Yuk-Yam Cheung; Wai-U Lo; Zhen Li; Kin-Hung Chow; Chi-Ho Lin; Jasper Fuk-Woo Chan; Vincent Chi-Chung Cheng
Journal:  Curr Microbiol       Date:  2013-06-01       Impact factor: 2.188

3.  Complete nucleotide sequence of a blaKPC-harboring IncI2 plasmid and its dissemination in New Jersey and New York hospitals.

Authors:  Liang Chen; Kalyan D Chavda; Nahed Al Laham; Roberto G Melano; Michael R Jacobs; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

4.  Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.

Authors:  Alex Agyekum; Alicia Fajardo-Lubián; Xiaoman Ai; Andrew N Ginn; Zhiyong Zong; Xuejun Guo; John Turnidge; Sally R Partridge; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

5.  A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae.

Authors:  Anna F Lau; Honghui Wang; Rebecca A Weingarten; Steven K Drake; Anthony F Suffredini; Mark K Garfield; Yong Chen; Marjan Gucek; Jung-Ho Youn; Frida Stock; Hanna Tso; Jim DeLeo; James J Cimino; Karen M Frank; John P Dekker
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

6.  Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity.

Authors:  Kirk Nelson; Peera Hemarajata; Dongxu Sun; Debora Rubio-Aparicio; Ruslan Tsivkovski; Shangxin Yang; Robert Sebra; Andrew Kasarskis; Hoan Nguyen; Blake M Hanson; Shana Leopold; George Weinstock; Olga Lomovskaya; Romney M Humphries
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

7.  Surveillance and characterization of carbapenemase-producing Klebsiella pneumoniae recovered from patient stool samples at a tertiary care medical center.

Authors:  Dixie F Mollenkopf; Roger L Faubel; Preeti Pancholi; Timothy F Landers; Matthew M Erdman; Joshua B Daniels; Thomas E Wittum
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

8.  Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.

Authors:  Sheila Adams-Sapper; Shantell Nolen; Grace Fox Donzelli; Mallika Lal; Kunihiko Chen; Livia Helena Justo da Silva; Beatriz M Moreira; Lee W Riley
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

9.  Complete sequence of a bla(KPC)-harboring cointegrate plasmid isolated from Escherichia coli.

Authors:  Kalyan D Chavda; Liang Chen; Michael R Jacobs; Albert D Rojtman; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

10.  In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.

Authors:  Alessandra Carattoli; Ea Zankari; Aurora García-Fernández; Mette Voldby Larsen; Ole Lund; Laura Villa; Frank Møller Aarestrup; Henrik Hasman
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.